182 related articles for article (PubMed ID: 25115442)
1. Granulin-epithelin precursor interacts with heparan sulfate on liver cancer cells.
Yip CW; Cheung PF; Leung IC; Wong NC; Cheng CK; Fan ST; Cheung ST
Carcinogenesis; 2014 Nov; 35(11):2485-94. PubMed ID: 25115442
[TBL] [Abstract][Full Text] [Related]
2. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma.
Yip CW; Lam CY; Poon TCW; Cheung TT; Cheung PFY; Fung SW; Wang XQ; Leung ICY; Ng LWC; Lo CM; Tsao GSW; Cheung ST
BMC Cancer; 2017 Jun; 17(1):409. PubMed ID: 28601093
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma.
Lam CY; Yip CW; Poon TC; Cheng CK; Ng EW; Wong NC; Cheung PF; Lai PB; Ng IO; Fan ST; Cheung ST
PLoS One; 2012; 7(7):e40324. PubMed ID: 22792281
[TBL] [Abstract][Full Text] [Related]
4. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST
Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873
[TBL] [Abstract][Full Text] [Related]
5. Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.
Yung MK; Lo KW; Yip CW; Chung GT; Tong CY; Cheung PF; Cheung TT; Poon RT; So S; Fan ST; Cheung ST
BMC Cancer; 2015 Apr; 15():264. PubMed ID: 25885205
[TBL] [Abstract][Full Text] [Related]
6. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
[TBL] [Abstract][Full Text] [Related]
7. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
8. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
Park MY; Park YS; Nam JH
Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
[TBL] [Abstract][Full Text] [Related]
9. Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.
Wong NC; Cheung PF; Yip CW; Chan KF; Ng IO; Fan ST; Cheung ST
Mol Cancer Ther; 2014 Dec; 13(12):3001-12. PubMed ID: 25253787
[TBL] [Abstract][Full Text] [Related]
10. Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.
Hoque M; Mathews MB; Pe'ery T
J Cell Physiol; 2010 Apr; 223(1):224-33. PubMed ID: 20054825
[TBL] [Abstract][Full Text] [Related]
11. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
[TBL] [Abstract][Full Text] [Related]
12. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.
Cheung ST; Cheung PF; Cheng CK; Wong NC; Fan ST
Gastroenterology; 2011 Jan; 140(1):344-55. PubMed ID: 20682318
[TBL] [Abstract][Full Text] [Related]
13. GEP associates with wild-type p53 in hepatocellular carcinoma.
Cheung ST; Wong SY; Lee YT; Fan ST
Oncol Rep; 2006 Jun; 15(6):1507-11. PubMed ID: 16685387
[TBL] [Abstract][Full Text] [Related]
14. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein.
Guo F; Lai Y; Tian Q; Lin EA; Kong L; Liu C
Arthritis Rheum; 2010 Jul; 62(7):2023-36. PubMed ID: 20506400
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1.
Hollósi P; Váncza L; Karászi K; Dobos K; Péterfia B; Tátrai E; Tátrai P; Szarvas T; Paku S; Szilák L; Kovalszky I
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977498
[TBL] [Abstract][Full Text] [Related]
16. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.
Ho JC; Ip YC; Cheung ST; Lee YT; Chan KF; Wong SY; Fan ST
Hepatology; 2008 May; 47(5):1524-32. PubMed ID: 18393387
[TBL] [Abstract][Full Text] [Related]
17. Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis.
Feng JQ; Guo FJ; Jiang BC; Zhang Y; Frenkel S; Wang DW; Tang W; Xie Y; Liu CJ
FASEB J; 2010 Jun; 24(6):1879-92. PubMed ID: 20124436
[TBL] [Abstract][Full Text] [Related]
18. OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2.
Song HH; Shi W; Filmus J
J Biol Chem; 1997 Mar; 272(12):7574-7. PubMed ID: 9065409
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.
Capurro MI; Xiang YY; Lobe C; Filmus J
Cancer Res; 2005 Jul; 65(14):6245-54. PubMed ID: 16024626
[TBL] [Abstract][Full Text] [Related]
20. Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo.
Zittermann SI; Capurro MI; Shi W; Filmus J
Int J Cancer; 2010 Mar; 126(6):1291-301. PubMed ID: 19816934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
